Abstract
The oceans are a source of combinatorial library of unique natural products, ‘not found in the terrestrial environment’. Marine invertebrates such as sponges, molluscs, bryozoans, tunicates (Urochordata) and their associated microorganisms are the major representatives of promising bioactive compounds. Among these, the predatory molluscan cone snails have evolved with highly structured small and complex array of peptides (more than 50,000) linked to their prey capture and defence. These peptides have become a valuable source of neuro pharmacological targets as many of them selectively modulate ion channels and transporters. A group of scientists from United States, Europe, Australia, Israel and China has characterized drugs for neuropathic pain and pharmacological targets from the peptides of a few cone snail species. Several are now in clinical and preclinical development. Less than 1% of the cono peptides are pharmacologically characterized. India has a diversity of 20-30% of total cone snail species distributed worldwide. A group of Indian Scientists has made promising drug discovery programs from Conus peptides. This review will focus on the Conus peptides from Indian cone snails species, their neuro pharmacological targets and future directions.
Keywords: Indian cone snails, Conus monile, fingerprint of conotoxins, pharmacological targets, voltage gated sodium channels, calcium channels, potassium channels, sponges, molluscs, bryozoans, tunicates (Urochordata), Conus peptides, conidae, Conus araneosus, Conus betulinus, Conus virgo, Conus loroisii, Conus amadis, Conus achatinus, Conus inscriptus, Conus textile, Conus hyaena, Conotoxins
Mini-Reviews in Medicinal Chemistry
Title: Novel Pharmacological Targets From Indian Cone Snails
Volume: 11 Issue: 2
Author(s): M. Santhana Ramasamy and S. Manikandan
Affiliation:
Keywords: Indian cone snails, Conus monile, fingerprint of conotoxins, pharmacological targets, voltage gated sodium channels, calcium channels, potassium channels, sponges, molluscs, bryozoans, tunicates (Urochordata), Conus peptides, conidae, Conus araneosus, Conus betulinus, Conus virgo, Conus loroisii, Conus amadis, Conus achatinus, Conus inscriptus, Conus textile, Conus hyaena, Conotoxins
Abstract: The oceans are a source of combinatorial library of unique natural products, ‘not found in the terrestrial environment’. Marine invertebrates such as sponges, molluscs, bryozoans, tunicates (Urochordata) and their associated microorganisms are the major representatives of promising bioactive compounds. Among these, the predatory molluscan cone snails have evolved with highly structured small and complex array of peptides (more than 50,000) linked to their prey capture and defence. These peptides have become a valuable source of neuro pharmacological targets as many of them selectively modulate ion channels and transporters. A group of scientists from United States, Europe, Australia, Israel and China has characterized drugs for neuropathic pain and pharmacological targets from the peptides of a few cone snail species. Several are now in clinical and preclinical development. Less than 1% of the cono peptides are pharmacologically characterized. India has a diversity of 20-30% of total cone snail species distributed worldwide. A group of Indian Scientists has made promising drug discovery programs from Conus peptides. This review will focus on the Conus peptides from Indian cone snails species, their neuro pharmacological targets and future directions.
Export Options
About this article
Cite this article as:
Santhana Ramasamy M. and Manikandan S., Novel Pharmacological Targets From Indian Cone Snails, Mini-Reviews in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/138955711794519500
DOI https://dx.doi.org/10.2174/138955711794519500 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monitoring Antiepileptic Drugs: A Level-Headed Approach
Current Neuropharmacology Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Pharmacological Inhibition of Voltage-gated Ca<sup>2+</sup> Channels for Chronic Pain Relief
Current Neuropharmacology Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Current Drug Targets Pyrrolizidine Alkaloids and their Biological Properties from Indian Heliotropium Species
Current Bioactive Compounds Polymeric Materials and Formulation Technologies for Modified-Release Tablet Development
Mini-Reviews in Medicinal Chemistry Spontaneous Recurrent Seizures Mediated Cardiac Dysfunction via mTOR Pathway Upregulation: A Putative Target for SUDEP Management
CNS & Neurological Disorders - Drug Targets Cyclooxygenase-2 in Synaptic Signaling
Current Pharmaceutical Design Genetics of Recurrent Vertigo and Vestibular Disorders
Current Genomics Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
Current Drug Safety Brain Permeable Nanoparticles
Recent Patents on CNS Drug Discovery (Discontinued) HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
Current HIV Research Near Infrared Optical Technologies to Illuminate the Status of the Neonatal Brain
Current Pediatric Reviews Phytochemicals: Potential in Management of Climacteric Neurobiology
Current Pharmaceutical Design Synthesis and Evaluation of the Anticonvulsant Activity of 5-alkylthio-4- phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one Derivatives
Letters in Drug Design & Discovery High Temperature Unfolding Simulations of a Single-stranded DNA i-Motif
Current Physical Chemistry Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases
Current Neuropharmacology Coenzyme Q10 and Neurological Diseases: An Update
Letters in Drug Design & Discovery An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design Therapeutic Potential of Peptide Toxins that Target Ion Channels
Inflammation & Allergy - Drug Targets (Discontinued)